2026 Adult Preventive Care Guidelines
The most important preventive measure for adults in 2026 remains promoting a healthy lifestyle throughout life, with specific emphasis on cardiovascular disease prevention through risk-stratified screening, appropriate vaccinations including updated RSV and pneumococcal recommendations, and evidence-based cancer screening protocols. 1, 2, 3
Cardiovascular Disease Prevention
Risk Assessment Framework
- Adults aged 40-75 years require 10-year ASCVD risk estimation before starting pharmacological therapy (statins, antihypertensives, or aspirin) 1
- Use the ACC/AHA Pooled Cohort Equations (PCE) to calculate 10-year risk, recognizing it may overestimate risk in contemporary populations 4
- For borderline risk (5% to <7.5%) or intermediate risk (≥7.5% to <20%), consider additional risk-enhancing factors:
- Family history of premature ASCVD
- Elevated Lp(a) ≥50 mg/dL (or ≥100 nmol/L) 5
- Chronic kidney disease
- Metabolic syndrome
- Inflammatory conditions
- Coronary artery calcium (CAC) scoring is reasonable for intermediate-risk adults when treatment decisions remain uncertain 1
Lipid Management
- Measure Lp(a) once in a lifetime during initial lipid screening 5
- Statin therapy is first-line for:
- LDL-C ≥190 mg/dL
- Diabetes mellitus patients aged 40-75 years
- Sufficient ASCVD risk after clinician-patient discussion 1
- Screen lipids every 5 years starting at age 40; annual assessment for those near treatment thresholds 4
Blood Pressure Management
- For stage 2 hypertension, initiate two first-line agents in a single-pill fixed-dose combination 3
- Target BP generally <130/80 mm Hg 1
- For cardiovascular disease risk <7.5% by PREVENT calculator, start medication if BP remains ≥130/80 mm Hg after 3-6 months of lifestyle modification 3
- Home blood pressure monitoring combined with multidisciplinary team support improves control rates; avoid cuffless devices (smartwatches) until better validated 3
- Severe hypertension (>180/120 mm Hg) without acute organ damage should be managed outpatient with oral medications 3
Aspirin Use
- Aspirin should be used infrequently in routine primary prevention due to lack of net benefit 1
Lifestyle Interventions (Universal Recommendations)
Diet
- Emphasize vegetables, fruits, nuts, whole grains, lean protein, and fish 1
- Minimize trans fats, processed meats, refined carbohydrates, and sweetened beverages 1, 6
- Limit red and cured meats, highly processed foods high in fats and sugars 6
- Limit sugar-sweetened beverages and alcohol consumption 6
Physical Activity
- Minimum 150 minutes/week of moderate-intensity OR 75 minutes/week of vigorous-intensity aerobic activity 1
- Avoid physical inactivity; incorporate daily movement (stairs, parking farther away) 6
- Strengthening activities at least twice weekly 7
Weight Management
- Achieve and maintain healthy body weight (BMI 18.5-30) 1, 6
- For overweight/obesity: counseling and caloric restriction 1
Tobacco Cessation
- Assess tobacco use at every healthcare visit 1
- Strongly advise and assist all tobacco users to quit, including e-cigarettes and hookah 6
- Avoid secondhand smoke exposure 6
Sleep
Immunizations (2025 Updates)
Universal Recommendations
- Pneumococcal vaccination now recommended for all adults ≥50 years (expanded from age 65); PCV21 added as an option 2
- RSV vaccination universal for adults ≥75 years and all pregnant persons 2
- Annual influenza vaccination for all adults 2
Risk-Based Recommendations
- RSV for adults aged 60-74 years with medical conditions increasing severe RSV risk (self-attestation acceptable) 2
- Pneumococcal for adults aged 19-49 years with risk factors 2
- Meningococcal (MenACWY and MenB): Updated schedules with MenB now 2-dose series (0,6 months) for healthy persons aged 16-23 via shared decision-making; 3-dose series (0,1-2,6 months) for high-risk adults 2
- Mpox vaccination for health care personnel not routinely recommended for occupational risk 2
Diabetes Prevention and Management
- Type 2 diabetes: Lifestyle changes (diet, exercise) are crucial 1
- Metformin is first-line pharmacotherapy 1
- Consider SGLT-2 inhibitor or GLP-1 receptor agonist as second-line 1
Team-Based Care Approach
A multidisciplinary team-based care approach is recommended for cardiovascular disease prevention 1, 8
Team should include:
- Clinicians
- Nurses/physician assistants
- Physical therapists
- Dieticians
- Social workers
- Patient navigators
- Certified exercise professionals
- Health coaches
- Tobacco treatment specialists 6
Evaluate social determinants of health to inform treatment decisions 1, 8
Cancer Screening
While specific cancer screening protocols are referenced in the evidence 9, detailed recommendations require consultation of specialty-specific guidelines for breast, cervical, colorectal, and lung cancer screening based on age and risk factors.
Preventive Care Delivery
Visit-Based Implementation
- Pre-visit planning checklists improve preventive care delivery, particularly for adults ≥50 years 10
- Staff should review charts before appointments to identify needed screenings, vaccinations, and counseling 10
- Periodic cardiovascular risk assessment from ages 40-75 with annual BP and smoking status checks 4
Common Pitfalls to Avoid
- Relying on age alone for statin decisions without considering overall risk profile 4
- Using cuffless BP devices (smartwatches) for clinical decisions 3
- Prescribing aspirin routinely for primary prevention 1
- Missing opportunities for Lp(a) screening (measure once lifetime) 5
- Delaying pneumococcal vaccination until age 65 (now recommended at 50) 2
Health Equity Considerations
Significant racial/ethnic disparities exist in preventive care adherence, particularly for vaccinations and cancer screening among AIAN, Black, Spanish-speaking Latino, MENA, and multiracial adults 11. Address barriers through culturally tailored interventions and systematic approaches to reduce missed opportunities.